Journal of Leukocyte Biology BioLegend: Treg, Th17, Stem Cell
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.0103010 on May 22, 2003

Published online before print May 22, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0103010v1
74/2/186    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kusmartsev, S.
Right arrow Articles by Gabrilovich, D. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kusmartsev, S.
Right arrow Articles by Gabrilovich, D. I.
(Journal of Leukocyte Biology. 2003;74:186-196.)
© 2003 by Society for Leukocyte Biology

Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species

Sergei Kusmartsev and Dmitry I. Gabrilovich

H. Lee Moffitt Cancer Center, University of South Florida, Tampa

Correspondence: Dmitry Gabrilovich, M.D., Ph.D., H. Lee Moffitt Cancer Center, University of South Florida, MRC-2, Room 2067, 12902 Magnolia Dr., Tampa, FL 33612. E-mail: dgabril{at}moffitt.usf.edu

It is well established that tumor growth is associated with accumulation of immature myeloid cells (ImC). They play an important role in tumor-associated immune suppression. ImC accumulate not only in tumor-bearing hosts but also in immunized, tumor-free hosts or hosts infected with bacterial pathogens. The kinetics of ImC in these mice is different. If in tumor-bearing mice, the number of ImC continues to increase with tumor progression in tumor-free mice after an initial spike, it decreases to the control level. Here, we have investigated the mechanisms of ImC accumulation in tumor-bearing hosts by comparing differentiation of ImC obtained from tumor-free and tumor-bearing mice. In the presence of appropriate growth factors, ImC isolated from tumor-free mice quickly differentiated in vitro into mature dendritic cells (DC), macrophages, and granulocytes. In contrast, differentiation of ImC from tumor-bearing mice was significantly delayed. Similar results were obtained in vivo after adoptive transfer of ImC into naïve, congeneic mice. ImC transferred into tumor-bearing recipients failed to differentiate into DC or macrophages. ImC from tumor-bearing mice had significantly higher levels of reactive oxygen species (ROS) than ImC obtained from tumor-free mice. Hydrogen peroxide (H2O2) but not superoxide radical anions was found to be the major part of this increased ROS production. In vitro experiments demonstrated that scavenging of H2O2 with catalase induced differentiation of ImC from tumor-bearing mice into macrophages. Thus, this is a first demonstration that tumors may prevent differentiation of antigen-presenting cells by increasing the level of endogenous H2O2 in immature myeloid cells.

Key Words: macrophages • dendritic cells • cell differentiation




This article has been cited by other articles:


Home page
BloodHome page
Y. Sawanobori, S. Ueha, M. Kurachi, T. Shimaoka, J. E. Talmadge, J. Abe, Y. Shono, M. Kitabatake, K. Kakimi, N. Mukaida, et al.
Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice
Blood, June 15, 2008; 111(12): 5457 - 5466.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P.-Y. Pan, G. X. Wang, B. Yin, J. Ozao, T. Ku, C. M. Divino, and S.-H. Chen
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
Blood, January 1, 2008; 111(1): 219 - 228.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Nefedova, M. Fishman, S. Sherman, X. Wang, A. A. Beg, and D. I. Gabrilovich
Mechanism of All-Trans Retinoic Acid Effect on Tumor-Associated Myeloid-Derived Suppressor Cells
Cancer Res., November 15, 2007; 67(22): 11021 - 11028.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. Filipazzi, R. Valenti, V. Huber, L. Pilla, P. Canese, M. Iero, C. Castelli, L. Mariani, G. Parmiani, and L. Rivoltini
Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor-Based Antitumor Vaccine
J. Clin. Oncol., June 20, 2007; 25(18): 2546 - 2553.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. J. Delano, P. O. Scumpia, J. S. Weinstein, D. Coco, S. Nagaraj, K. M. Kelly-Scumpia, K. A. O'Malley, J. L. Wynn, S. Antonenko, S. Z. Al-Quran, et al.
MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis
J. Exp. Med., June 11, 2007; 204(6): 1463 - 1474.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Q. Ding, T. Jin, Z. Wang, and Y. Chen
Catalase potentiates retinoic acid-induced THP-1 monocyte differentiation into macrophage through inhibition of peroxisome proliferator-activated receptor {gamma}
J. Leukoc. Biol., June 1, 2007; 81(6): 1568 - 1576.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Vieweg, Z. Su, P. Dahm, and S. Kusmartsev
Reversal of Tumor-Mediated Immunosuppression
Clin. Cancer Res., January 15, 2007; 13(2): 727s - 732s.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Cheng, Y. Nefedova, C. A. Corzo, and D. I. Gabrilovich
Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands
Blood, January 15, 2007; 109(2): 507 - 515.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Mirza, M. Fishman, I. Fricke, M. Dunn, A. M. Neuger, T. J. Frost, R. M. Lush, S. Antonia, and D. I. Gabrilovich
All-trans-Retinoic Acid Improves Differentiation of Myeloid Cells and Immune Response in Cancer Patients.
Cancer Res., September 15, 2006; 66(18): 9299 - 9307.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. A. Van Ginderachter, S. Meerschaut, Y. Liu, L. Brys, K. De Groeve, G. Hassanzadeh Ghassabeh, G. Raes, and P. De Baetselier
Peroxisome proliferator-activated receptor {gamma} (PPAR{gamma}) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer
Blood, July 15, 2006; 108(2): 525 - 535.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Yang, Z. Cai, Y. Zhang, W. H. Yutzy IV, K. F. Roby, and R. B.S. Roden
CD80 in Immune Suppression by Mouse Ovarian Carcinoma-Associated Gr-1+CD11b+ Myeloid Cells.
Cancer Res., July 1, 2006; 66(13): 6807 - 6815.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Lizee, L. G. Radvanyi, W. W. Overwijk, and P. Hwu
Immunosuppression in melanoma immunotherapy: potential opportunities for intervention.
Clin. Cancer Res., April 1, 2006; 12(7): 2359s - 2365s.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Z. F. M. Vasconcelos, B. M. dos Santos, J. Farache, T. S. S. Palmeira, R. B. Areal, J. M. T. Cunha, M. A. Barcinski, and A. Bonomo
G-CSF-treated granulocytes inhibit acute graft-versus-host disease
Blood, March 1, 2006; 107(5): 2192 - 2199.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Nefedova, S. Nagaraj, A. Rosenbauer, C. Muro-Cacho, S. M. Sebti, and D. I. Gabrilovich
Regulation of Dendritic Cell Differentiation and Antitumor Immune Response in Cancer by Pharmacologic-Selective Inhibition of the Janus-Activated Kinase 2/Signal Transducers and Activators of Transcription 3 Pathway
Cancer Res., October 15, 2005; 65(20): 9525 - 9535.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Kusmartsev, S. Nagaraj, and D. I. Gabrilovich
Tumor-Associated CD8+ T Cell Tolerance Induced by Bone Marrow-Derived Immature Myeloid Cells
J. Immunol., October 1, 2005; 175(7): 4583 - 4592.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Kusmartsev and D. I. Gabrilovich
STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion
J. Immunol., April 15, 2005; 174(8): 4880 - 4891.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Sinha, V. K. Clements, and S. Ostrand-Rosenberg
Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic Disease
J. Immunol., January 15, 2005; 174(2): 636 - 645.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. J. Skeen, M. M. Freeman, and H. K. Ziegler
Changes in peritoneal myeloid populations and their proinflammatory cytokine expression during infection with Listeria monocytogenes are altered in the absence of {gamma}/{delta} T cells
J. Leukoc. Biol., July 1, 2004; 76(1): 104 - 115.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Kusmartsev, Y. Nefedova, D. Yoder, and D. I. Gabrilovich
Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species
J. Immunol., January 15, 2004; 172(2): 989 - 999.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Nefedova, M. Huang, S. Kusmartsev, R. Bhattacharya, P. Cheng, R. Salup, R. Jove, and D. Gabrilovich
Hyperactivation of STAT3 Is Involved in Abnormal Differentiation of Dendritic Cells in Cancer
J. Immunol., January 1, 2004; 172(1): 464 - 474.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society for Leukocyte Biology.